Blockade of TGF-β action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis

Kidney International

Volumn 64, Issue 1, 2003, Pages 92-101

  Zhou, Aihua ^b   Ueno, Hikaru ^b   Shimomura, Mayumi ^b   Tanaka, Ryojiro ^b   Shirakawa, Toshiro ^b   Nakamura, Hajime ^b   Matsuo, Masafumi ^b   Iijima, Kazumoto ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NONE

Author keywords

Adenovirus vector; Anti GBM nephritis; Crescent formation; Interstitial fibrosis; Renal dysfunction; Soluble TGF receptor

Indexed keywords

BETA GALACTOSIDASE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE TRANSFER; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MESENCHYME CELL; MYOFIBROBLAST; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR BLOCKING;

EID: 0037792930     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00045.x     Document Type: Article

References (37)

1. BORDER WA, NOBLE NA: Transforming growth factor-beta in glomerular injury. Exp Nephrol 2:13-17, 1994
2. SUN Y, CLEUTJENS JP, DIAZ-ARIAS AA, WEBER KT: Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28:1423-1432, 1994
3. BISHOP JE, RHODES S, LAURENT GJ, et al: Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload. Cardiovasc Res 28:1581-1585, 1994
4. MIETTINEN PJ, EBNER R, LOPEZ AR, DERYNCK R: TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J Cell Biol 127:2021-2036, 1994
5. NG YY, FAN JM, MU W, et al: Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 14:2860-2872, 1999
6. EDWARDS DR, MURPHY G, REYNOLDS JJ, et al: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
7. ROBERTS CJ, BIRKENMEIER TM, MCQUILLAN JJ, et al: Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 263:4586-4592, 1988
8. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
9. UENO H, SAKAMOTO T, NAKAMURA T, et al: A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11:33-42, 2000
10. SAKAMOTO T, UENO H, SONODA K, et al: Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Ther 7:1915-1924, 2000
11. BORDER WA, OKUDA S, LANGUINO LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346:371-374, 1990
12. ISAKA Y, AKAGI Y, ANDO Y, et al: Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55:465-475, 1999
13. AKAGI Y, ISAKA Y, ARAI M, et al: Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
14. BORDER WA, NOBLE NA, YAMAMOTO T, et al: Antagonists of transforming growth factor-beta: A novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 41:566-570, 1992
15. COIMBRA T, WIGGINS R, NOH JW, et al: Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-234, 1991
16. IIJIMA K, HAMAHIRA K, KOBAYASHI A, et al: Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome. J Am Soc Nephrol 11:2265-2271, 2000
17. BORDER WA, NOBLE NA: TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int 51:1388-1396, 1997
18. ALPERS CE, HUDKINS KL, GOWN AM, JOHNSON RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
19. ALPERS CE, HUDKINS KL, FLOEGE J, JOHNSON RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 5:201-209, 1994
20. ZHANG G, MOORHEAD PJ, EL NAHAS AM: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 3:308-318, 1995
21. GOUMENOS DS, BROWN CB, SHORTLAND J, EL NAHAS AM: Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 9:1418-1425, 1994
22. WEBER KT: Fibrosis, a common pathway to organ failure: Angiotensin II and tissue repair. Semin Nephrol 17:467-491, 1997
23. FUJIGAKI Y, SUN DF, FUJIMOTO T, et al: Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats. Virchows Arch 439:35-45, 2001
24. YANG J, LIU Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13:96-107, 2002
25. YANG J, LIU Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475, 2001
26. SHULL MM, ORMSBY I, KIER AB, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
27. KANAMARU Y, NAKAO A, MAMURA M, et al: Blockade of TGF-beta signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 166:2818-2823, 2001
28. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287, 1994
29. SCHNEIDER A, HARENDZA S, ZAHNER G, et al: Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int 55:430-441, 1999
30. FUJINAKA H, YAMAMOTO T, TAKEYA M, et al: Suppression of antiglomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats. J Am Soc Nephrol 8:1174-1178, 1997
31. CHEN S, BACON KB, LI L, et al: In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188:193-198, 1998
32. NATORI Y, SEKIGUCHI M, OU Z, NATORI Y: Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin Exp Immunol 109:143-148, 1997
33. TANG WW, QI M, WARREN JS: Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int 50:665-671, 1996
34. WADA T, YOKOYAMA H, FURUICHI K, et al: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 10:1418-1425, 1996
35. KAWACHI H, IWANAGA T, TOYABE S, et al: Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injection of monoclonal antibody 1-22-3. Clin Exp Immunol 90:129-134, 1992
36. LAN HY, NIKOLIC-PATERSON DJ, ATKINS RC: Trafficking of inflammatory macrophages from the kidney to draining lymphnodes during experimental glomerulonephrotis. Clin Exp Immunol 92:336-341, 1993
37. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-b and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990